The ability of ECE to alter the G-CSF/gMDSC axis in the 4T1 model illustrates that local ECE treatment can promote anti-tumor/metastatic effects via systemic immunomodulation of pro-tumorigenic factors and amelioration of immunosuppressive functions by tumor-entrained myeloid cells. This evidence concerns the gene CSF3 and neoplasm.